XML 74 R63.htm IDEA: XBRL DOCUMENT v3.24.3
Financial Instruments - Information About Changes in Liabilities for Contingent Consideration (Details)
$ in Millions
9 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value, beginning balance $ 354 $ 456
Changes in estimated fair value 2 6
Payments (148) (117)
Fair value, ending balance 208 $ 345
Current liability 163  
Sanofi Pasteur    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Payments (126)  
Current liability $ 136  
Contingent consideration, measurement input, discount rate 0.115